WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IOVA

Based on 9 analysts offering 12 month price targets for Iovance Biotherapeutics Inc

Min Forecast
$7.00-50.81%
Avg Forecast
$13.11-7.86%
Max Forecast
$20.00+40.55%

Should I buy or sell IOVA stock?

Based on 9 analysts offering ratings for Iovance Biotherapeutics Inc.

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
3 analysts 33.33%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IOVA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IOVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their IOVA stock forecasts and price targets.

IOVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-30Find Out Why
lockedlocked$00.00+00.00%2026-09-29
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-17Find Out Why
lockedlocked$00.00+00.00%2026-08-25
UBS
Top 26%
75
HoldMaintains$7.00-50.81%2026-08-20
Mizuho
Top 34%
67
BuyMaintains$11.00-22.70%2026-08-18
Citizens
Top 17%
84
BuyMaintains$8.00-43.78%2026-08-07
Chardan Capital
Top 2%
99
Strong BuyMaintains$14.00-1.62%2026-05-07

1 of 1

Forecast return on equity

Is IOVA forecast to generate an efficient return?

Company
13.5%
Industry
20.21%
Market
168.91%
IOVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IOVA forecast to generate an efficient return on assets?

Company
10.85%
Industry
22.48%
IOVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IOVA earnings per share forecast

What is IOVA's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.51
Avg 2 year Forecast
-$0.28
Avg 3 year Forecast
$0.08

IOVA revenue forecast

What is IOVA's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$406.5M+25.1%
Avg 2 year Forecast
$566.0M+74.16%
Avg 3 year Forecast
$864.7M+166.08%
IOVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IOVA revenue growth forecast

How is IOVA forecast to perform vs Biotechnology companies and vs the US market?

Company
37.22%
Industry
30.55%
Market
14.48%
IOVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IOVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IOVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IOVA$14.23$13.11-7.86%Strong Buy
RYTM$93.41$147.14+57.52%Strong Buy
BLTE$162.98$251.60+54.37%Strong Buy
KOD$98.46$87.33-11.30%Strong Buy
CGON$68.35$87.50+28.02%Strong Buy
View Top Biotech Stocks

Iovance Biotherapeutics Stock Forecast FAQ

Is Iovance Biotherapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: IOVA) stock is to Strong Buy IOVA stock.

Out of 9 analysts, 5 (55.56%) are recommending IOVA as a Strong Buy, 3 (33.33%) are recommending IOVA as a Buy, 1 (11.11%) are recommending IOVA as a Hold, 0 (0%) are recommending IOVA as a Sell, and 0 (0%) are recommending IOVA as a Strong Sell.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.

What is IOVA's earnings growth forecast for 2026-2028?

(NASDAQ: IOVA) Iovance Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.54%.

Iovance Biotherapeutics's earnings in 2026 is -$289,517,000.On average, 11 Wall Street analysts forecast IOVA's earnings for 2026 to be -$229,928,299, with the lowest IOVA earnings forecast at -$257,468,962, and the highest IOVA earnings forecast at -$212,624,790. On average, 11 Wall Street analysts forecast IOVA's earnings for 2027 to be -$125,473,087, with the lowest IOVA earnings forecast at -$185,537,099, and the highest IOVA earnings forecast at -$80,855,401.

In 2028, IOVA is forecast to generate $35,195,880 in earnings, with the lowest earnings forecast at -$55,036,029 and the highest earnings forecast at $95,124,001.

What is IOVA's revenue growth forecast for 2026-2028?

(NASDAQ: IOVA) Iovance Biotherapeutics's forecast annual revenue growth rate of 37.22% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Iovance Biotherapeutics's revenue in 2026 is $324,969,000.On average, 11 Wall Street analysts forecast IOVA's revenue for 2026 to be $184,151,005,965, with the lowest IOVA revenue forecast at $166,467,001,260, and the highest IOVA revenue forecast at $200,589,339,233. On average, 11 Wall Street analysts forecast IOVA's revenue for 2027 to be $256,368,241,369, with the lowest IOVA revenue forecast at $226,395,121,714, and the highest IOVA revenue forecast at $291,251,571,347.

In 2028, IOVA is forecast to generate $391,675,337,822 in revenue, with the lowest revenue forecast at $319,263,324,702 and the highest revenue forecast at $588,409,890,168.

What is IOVA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IOVA) forecast ROA is 10.85%, which is lower than the forecast US Biotechnology industry average of 22.48%.

What is IOVA's Price Target?

According to 9 Wall Street analysts that have issued a 1 year IOVA price target, the average IOVA price target is $13.11, with the highest IOVA stock price forecast at $20.00 and the lowest IOVA stock price forecast at $7.00.

On average, Wall Street analysts predict that Iovance Biotherapeutics's share price could fall to $13.11 by Sep 30, 2027. The average Iovance Biotherapeutics stock price prediction forecasts a potential downside of 7.86% from the current IOVA share price of $14.23.

What is IOVA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IOVA) Iovance Biotherapeutics's current Earnings Per Share (EPS) is -$0.70. On average, analysts forecast that IOVA's EPS will be -$0.51 for 2026, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.47. On average, analysts forecast that IOVA's EPS will be -$0.28 for 2027, with the lowest EPS forecast at -$0.41, and the highest EPS forecast at -$0.18. In 2028, IOVA's EPS is forecast to hit $0.08 (min: -$0.12, max: $0.21).

What is IOVA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IOVA) forecast ROE is 13.5%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.